Name of Depositor
|
Adeno-associated Virus Reference Standard Working Group (AAVRSWG)
|
References
|
Ayuso E, et al. Reference materials for the characterization of adeno-associated viral vectors. In: Cohen-haguenauer, O (ed). The Clinibook: clinical gene transfer state of the art. EDK: Paris: pp. 83-90, 2012.
Moullier P, Snyder RO. Recombinant adeno-associated viral vector reference standards. Methods Enzymol. 507: 297-311, 2012. PubMed: 22365780
Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008.
Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177
Tessier J, et al. Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J. Virol. 75(1):375-383, 2001. PubMed: 11119606
Lock M, et al. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum. Gene Ther. 21(10): 1273-1285, 2010. PubMed: 20486768
Ayuso E, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 17(4): 503-510, 2010. PubMed: 19956269
|